22246-83-9

Basic information

• Product Name: 2H-1-BENZAZEPIN-2-ONE, 1,3,4,5-TETRAHYDRO-8-METHOXY-
• Synonyms: 2H-1-BENZAZEPIN-2-ONE, 1,3,4,5-TETRAHYDRO-8-METHOXY-;8-METHOXY-1,3,4,5-TETRAHYDRO-BENZO[B]AZEPIN-2-ONE;8-methoxy-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
• CAS NO: 22246-83-9
• Molecular Formula: C₁₁H₁₃NO₂
• Molecular Weight: 191.23
• Mol File: 22246-83-9.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 369.8°C at 760 mmHg
• Flash Point: 177.5°C
• Appearance: /
• Density: 1.121g/cm³
• Vapor Pressure: 1.16E-05mmHg at 25°C
• Refractive Index: 1.536
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2H-1-BENZAZEPIN-2-ONE, 1,3,4,5-TETRAHYDRO-8-METHOXY-(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-1-BENZAZEPIN-2-ONE, 1,3,4,5-TETRAHYDRO-8-METHOXY-(22246-83-9)
• EPA Substance Registry System: 2H-1-BENZAZEPIN-2-ONE, 1,3,4,5-TETRAHYDRO-8-METHOXY-(22246-83-9)

Safety Data

• Hazardous Substances Data: 22246-83-9(Hazardous Substances Data)

Usage

General Description

2H-1-Benzazepin-2-one, 1,3,4,5-tetrahydro-8-methoxy- is a chemical compound with the molecular formula C14H17NO2. It belongs to the class of benzazepine compounds, which are heterocyclic compounds containing a seven-membered ring with a nitrogen atom. This particular compound also contains a methoxy group, which is a functional group consisting of a methyl group linked to an oxygen atom. It is used in pharmaceutical research and drug development, where it may have potential applications in the treatment of various medical conditions. The exact biological and pharmacological properties of this compound are still under investigation, but its unique chemical structure makes it a promising candidate for further exploration and study.

InChI:InChI=1/C11H13NO2/c1-14-9-6-5-8-3-2-4-11(13)12-10(8)7-9/h5-7H,2-4H2,1H3,(H,12,13)

Upstream product

• 6836-19-7 7-Methoxy-1-tetralone 
• 7664-93-9 sulfuric acid 
• 169303-80-4 tert-butyl (2-bromo-5-methoxyphenyl)carbamate 
• 20175-97-7 7-methoxy-3,4-dihydronaphthalen-1(2H)-one oxime 
• 99833-87-1 7-methoxy-1-tetralone O-tosyloxime 
• 887354-63-4 C₁₈H₁₉NO₃S 

Downstream Products

• 1439931-08-4 C₃₂H₃₀Cl₄N₂O₃ 
• 1202503-76-1 1-(2,4-dichlorophenyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl trifluoromethanesulfonate 
• 1202503-74-9 1-(2,4-dichlorophenyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-8-ol 
• 1202503-72-7 1-(2,4-dichlorophenyl)-8-methoxy-2,3,4,5-tetrahydro-1H-1-benzazepine 
• 22246-84-0 8-Hydroxy-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin 
• 340754-75-8 3(R,S)-tert-butoxycarbonyl-8-methoxy-2,3,4,5-tetrahydro-1H-1-benzazepine-2-one 
• 340754-87-2 1-tert-butoxycarbonyl-3(R,S)-tert-butoxycarbonyl-8-methoxy-2,3,4,5-tetrahydro-1H-1-benzazepine-2-one 

Relevant articles and documents

Benzo Annulenes as Antiviral Agents

The present disclosure is concerned with benzo annulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, usi

CARBOXY X RHODAMINE ANALOGS

The present invention provides novel fluorescent dyes and kits containing the same, which are useful for labeling a wide variety of biomolecules, cells and microorganisms. The present invention also provides various methods of using the fluorescent dyes f

FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS

The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R1, R2, R3, R4, R5, A1, A2, A3, A4, and A5, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders.